Carnitine-acylcarnitine translocase deficiency: case report and review of the literature.
OBJECTIVE
Carnitine-acylcarnitine translocase (CACT) deficiency is an inborn error of metabolism involving the mitochondrial beta-oxidation of long-chain fatty acids. The aim of this study was to report on a new case (neonatal phenotype) and review the literature data on 24 previously reported cases.


METHODS
Clinical data of the new case are described and compared with the previous reports.


RESULTS
The patient with a novel mutation had clinical features and biochemical findings similar to those of the other reported patients.


CONCLUSIONS
CACT is an entity in which clinical encephalopathy, hepatomegaly and arrythmias are common. Hyperammonaemia and elevation of creatine kinase seem to be constant findings as in other disorders of mitochondrial beta-oxidation of long-chain fatty acids. The mortality rate is very high.
Rubio-Gozalbo
M E
ME
Departments of Pediatrics, University Hospital Maastricht, The Netherlands. mrub@groupwise.azm.nl
Vos
P
P
Forget
P Ph
PP
Van Der Meer
S B
SB
Wanders
R J A
RJ
Waterham
H R
HR
Bakker
J A
JA
D002333:Carnitine Acyltransferases / Q000172:deficiency* / Q000235:genetics*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008661:Metabolism, Inborn Errors / Q000175:diagnosis* / Q000178:diet therapy / Q000235:genetics*
D002333:Carnitine Acyltransferases